-
Product Insights
Diabetic Peripheral Neuropathy: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Diabetic Peripheral Neuropathy - Global Clinical Trials Review, 2025" provides an overview of Diabetic Peripheral Neuropathy Clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Peripheral Neuropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Cholera: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Cholera - Global Clinical Trials Review, 2025" provides an overview of Cholera Clinical trials scenario. This report provides top line data relating to the clinical trials on Cholera. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Hyperparathyroidism, Hyperphosphatemia, and Hyperkalemia in Chronic Kidney Disease: Opportunity Assessment, Epidemiology, Disease Management, and Forecast to 2034
This report covers the 7MM (US, 5EU, Japan) and provides an Excel-based forecast model for the CKD-HPT, HP and HK market through 2034. • There will be an overall increase in the diagnosed prevalent cases of CKD- HPT, HP and HK in the 7MM across the forecast period. • Across the 7MM, the mainstay treatment for HPT, HP, and HK involves phosphate binders, calcimimetics, and potassium binders • Significant clinical and environmental unmet needs remain in the CKD- HPT, HP...
-
Thematic Analysis
Genomics: FutureTech Series
Genomic innovation is accelerating the transition to faster diagnostics, scalable biomanufacturing, and precision therapies. GlobalData’s latest FutureTech Series: Genomics report delivers a comprehensive analysis of the technologies redefining molecular healthcare. The report highlights automated DNA extraction, metagenomic pathogen detection, genome-edited iPSC therapies, plasmid DNA extraction kits, and isothermal DNA amplification, each positioned to address critical challenges in clinical reliability, decentralized testing, and therapeutic accessibility. Using GlobalData’s proprietary Tech Foresights platform, the report examines innovation drivers, challenges, patent leadership, and real-world...
-
Sector Analysis
American Heart Association (AHA): Scientific Sessions 2025 Highlights
The American Heart Association (AHA) Scientific Sessions is an annual, four-day conference that brings together cardiovascular healthcare professionals from around the world to share the latest advances, research, and guidelines in heart and vascular medicine. AHA 2025 took place in New Orlkeans, Louisiana, between 7-10 November 2025. GlobalData's cardiovascular & metabolic team attended industry-sponsored and scientific sessions where key therapies were featured, the contents of which were analyzed to create this AHA 2025 Highlights report.
-
Sector Analysis
IDWeek: Annual Meeting 2025 Highlights
IDWeek is the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases Society and the Society of Infectious Diseases Pharmacists. IDWeek 2025 took place in Atlanta, Georgia, between 19-22 October 2025. GlobalData's infectious diseases team attended industry-sponsored and scientific sessions where key therapies were featured, the contents of which were analyzed to create this IDWeek 2025 Highlights report.
-
Product Insights
Clinical Trials: A Look at Rescue Trials and Delayed Duration
This report provides an updated insight into the overall clinical trial landscape for rescue clinical trials from the previous report published in 2021 and also to examine the quantitative delayed value for these trials. This report provides an overview of rescue clinical trials and its quantitative delayed values captured from the GlobalData Pharma Intelligence Center until August 22, 2025.
-
Sector Analysis
Retinal Vein Occlusion: Market View, Current and Future Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in Retinal Vein Occlusion Therapeutics. • In 2024 and 2029, China is anticipated to have the highest number of diagnosed prevalent cases of BRVO, representing a large portion of global cases. • Currently, the RVO market lacks disease-modifying therapies, as no cure can reverse the blockage itself. Current treatments focus on managing complications like macular edema and neovascularization to stabilize vision and prevent further loss. • The RVO pipeline...
-
Thematic Analysis
FDI Trends in APAC (2025)
Overall, the Asia-Pacific (APAC) region experienced significant growth in inward Foreign Direct Investment (FDI) for 2024. This growth was primarily focused on sectors such as renewables, communications/media, and electronics, with the United States, United Kingdom, and France identified as major investors. In 2025, increasing trade barriers and geopolitical tensions are altering the landscape of APAC FDI. While protectionist measures and security-driven screening are redirecting some investments, such as semiconductors from Taiwan, towards the United States, resilient markets like India and...
-
Sector Analysis
Bio/Pharmaceutical Outsourcing Report, October 2025
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.